Carregant...
Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
PURPOSE: We evaluated the clinical responses and radiographic outcomes of 90 patients with rheumatoid arthritis (RA) undergoing continuous or dose-adjusted infliximab treatment over 104 weeks. PATIENTS AND METHODS: Patients received 3 mg/kg infliximab continuously (the contin group; n=50), or the do...
Guardat en:
| Publicat a: | Biologics |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267494/ https://ncbi.nlm.nih.gov/pubmed/30568425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S187998 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|